Oragenics Inc.

(NYSE:OGEN)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing Terra CoV-2 immunization product candidate to combat the novel coronavirus.

Contact Information

Website: www.oragenics.com
Email: johnm@coreir.com
Main Phone: +1 813 286-7900
Address: 4902 Eisenhower Boulevard
Address 2: Suite 125
State: FL
City / Town: Tampa
Country: US
Postal Code: 33634

Issuer Information

Exchange: AMX
CEO: Alan F. Joslyn
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A